About CIIC

The Cancer Immunology and Immunotherapy Centre (CIIC) is a collaborative grouping of around 30 academic and clinical research groups based at the University of Birmingham and the Queen Elizabeth Hospital Birmingham, collectively focussed on developing internationally outstanding basic tumour immunology research and translating key discoveries into improvements in cancer treatment.

The CIIC is a cross-centre grouping that draws on research expertise in four centres across the University’s Edgbaston campus: the School of Cancer Sciences, the Centre for Clinical Haematology, the School of Immunity and Infection, and Birmingham’s National Health Service Blood and Transplant service.

Research efforts are centred around a small number of main research themes, which address fundamental issues in tumour immunology: understanding which antigens to target, understanding the tumour microenvironment, and research into different therapeutic strategies. Clinically, these efforts are focussed upon haematological malignancies, and also a range of specific cancers within the solid tumours clinical theme.



“We aim to translate key advances in our understanding of tumour immunology into novel immunotherapy treatments that improve patient care, through creative collaborations between basic scientists and clinicians that exploit the unique environment in Birmingham for translational medicine.” Professor Ben Willcox, Director of the CIIC

These efforts are enhanced by national and international academic and industrial collaborations, described on our Partners and Industry page. An important part of the CIIC research programme involves training the next generation of academic and clinical cancer immunology researchers, outlined in our Studying/Teaching section.

Underpinning all research within CIIC is the need to translate key research findings into improvements in the effectiveness of current cancer treatments and/or improvements in quality of life for patients during treatment. To facilitate these efforts, CIIC research is closely integrated with the Cancer Research UK Clinical Trials Unit (CRCTU), one of the most well respected of its kind in the UK, providing a superb translational interface for novel CIIC research findings.


  • To learn more about the work of the CIIC, visit our News and Events, and Get Involved pages.
  • Do you want to make a difference to Cancer Immunology and Immunotherapy research by making a donation to the CIIC ? Click here to visit our Donations page.